FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1914-1916 June 13, 2002 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Brown, B. G. Related Article by Willett, W. C. PubMed Citation

To the Editor: Willett and Stampfer state in their Clinical Practice article (Dec. 20 issue)¹ that "assuming a low probability that vitamin E will eventually be proved efficacious [against coronary disease] (and we view the probability as fairly high), the likelihood of benefit would still outweigh the very low probability of harm." Brown et al. (Nov. 29 issue)² reported that, among patients with established coronary disease, the combination of antioxidants (800 IU of vitamin E, 25 mg of natural beta carotene, and 100 µg of selenium) with simvastatin and niacin resulted in less benefit than simvastatin and niacin alone. The . . . [Full Text of this Article]

References

This article has been cited by other articles:

• McNaughton, S. A., Mishra, G. D., Paul, A. A., Prynne, C. J., Wadsworth, M. E. J. (2005). Supplement Use Is Associated with Health Status and Health-Related Behaviors in the 1946 British Birth Cohort. J. Nutr. 135: 1782-1789 [Abstract] [Full Text]